This week, we will discuss the use of lanreotide - a somoatostatin analogue, for the treatment of autosomal dominant polycystic kidney disease. An RCT, published in JAMA.
Overdosed Donors: The Visual Abstract
For this #NephJC, Samira Farouk, from the NSMC class of 2018 and a nephrology fellow from Mount Sinai, NY, has not only written an excellent summary - but also created the visual abstract, and will be hosting the chat next week.
